Clinical Trial: The predictive value of baseline cardiovascular status in newly diagnosed multiple myeloma patients for treatment response and progression-free survival in the real world (China)

China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The predictive value of baseline cardiovascular status in newly diagnosed multiple myeloma patients for treatment response and progression-free survival in the real world'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133190

Registration Time: 2026/09/22

Type: Observational study

Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336367

Published by HT Digital Content Services with permission from Health Daily Digest....